MoneyWorks4Me

Natco Pharma submits analyst meet intimation

10 Feb 2025 Evaluate
Further to earlier intimation dated 3rd February, 2025, Natco Pharma has informed that the Earnings Call with Investors / Analysts on Thursday, the 13th February, 2025 at 11:00 AM IST has been preponed to Thursday, the 13th February, 2025 at 10:00 AM IST to discuss the Unaudited Financial Results of the Company for the quarter ended 31st December, 2024.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..